Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus
Clinical trial NCT04680637 · TERMINATED
Trial details
- NCT number
- NCT04680637
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-06
- Primary completion
- 2023-05-22
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.